Immunosuppressants, a class of medicines that broadly work to reduce immune system activity, are widely used to treat myasthenia gravis (MG).| Myasthenia Gravis News
Rituximab is an antibody-based therapy that may be used off-label in patients with certain types of myasthenia gravis.| Myasthenia Gravis News
Vyvgart is an approved infusion treatment for adults with generalized myasthenia gravis who are AChR-antibody positive.| Myasthenia Gravis News
Rystiggo is a myasthenia gravis treatment for adults with generalized MG. It's administered as an injection.| Myasthenia Gravis News
Batoclimab is an experimental antibody therapy being developed for generalized myasthenia gravis, along with other autoimmune disorders.| Myasthenia Gravis News
Getting a correct myasthenia gravis diagnosis may require a series of blood, nerve, muscle, and imaging tests.| Myasthenia Gravis News
Joana Carvalho is a managing science editor for BioNews with a PhD in biomedical sciences. She edits and fact-checks articles on a variety of rare and chronic disease topics.| Myasthenia Gravis News
Soliris (eculizumab) is an infusion therapy approved for treating adults with generalized myasthenia gravis.| Myasthenia Gravis News
Muscle weakness and fatigue are hallmark symptoms of myasthenia gravis (MG), an autoimmune disorder. MG symptoms may come and go.| Myasthenia Gravis News
Myasthenia gravis occurs when self-reactive antibodies mistakenly attack the body's immune system, causing muscle weakness and fatigue.| Myasthenia Gravis News
Mestinon (pyridostigmine bromide) is an oral therapy approved for the treatment of myasthenia gravis (MG).| Myasthenia Gravis News
Myasthenia gravis is a neuromuscular disease characterized by weakness and fatigue that can affect muscles involved in voluntary movements.| Myasthenia Gravis News